Comparing CT and MRI scans to plan internal radiation for prostate cancer
Compares two scan methods for planning internal radiation in adults with prostate cancer.
Key facts
- Who runs it
- Emory University
- Where
- Atlanta, United StatesSee the 3 sites
- Trial code
- Registry title
- CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate Cancer
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 22 Oct 2026
- Expected to end
- 31 May 2029
- Type of study
- Interventional, 2 groups
- Treatments tested
- Magnetic Resonance Imaging
- Questionnaire Administration
- Record updated
- 2 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for men with prostate cancer that has not spread, who plan to have HDR brachytherapy. It compares CT-based planning with MRI-based planning.
- Age
- 18 years or older
- Sex
- Men only
- Disease stage
- Prostate cancer confirmed by tissue examination, with no sign of spread to nearby areas or distant parts of the body
- Earlier treatment
- Men must plan treatment meant to remove all of the disease with HDR brachytherapy, with or without external beam radiation therapy. Men with earlier radiation to the pelvis cannot join.
Main reasons for not taking part
- Earlier radiation therapy to the pelvis
- No earlier MRI of the prostate
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Men ≥ 18 years old
- Histopathologically confirmed prostate cancer
- No evidence of regional or distant metastases
- Plan to undergo curative-intent HDR brachytherapy with or without external beam radiation therapy
Who cannot take part
- Prior pelvic radiation therapy
- No prior prostate MRI
Where in United States
- Emory Proton Therapy CenterAtlanta, United StatesContact: Ardith DeShayTaking people
- Emory University Hospital MidtownAtlanta, United StatesContact: Ardith DeshayTaking people
- Emory University Hospital/Winship Cancer InstituteAtlanta, United StatesContact: Ardith DeshayTaking people
About the trial
What the trial wants to find out
This clinical trial studies the safety of a computed tomography (CT) scan, with or without a magnetic resonance imaging (MRI) scan, in planning for high-dose-rate (HDR) prostate brachytherapy treatment in patients with prostate cancer. Brachytherapy is a type of radiation therapy in which radioactive implants, such as pellets, seeds, ribbons, wires, needles, balloons, or capsules, are placed in the body, directly into or near the tumor. The radiation is delivered through a flexible tube called a catheter or a larger device called an applicator. Treatment planning, or simulation, is a process used to plan radiation therapy so that the target area is precisely located and marked. A CT scan is a procedure that uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body. The pictures are taken from different angles and are used to create 3-dimensional views of tissues and organs. An MRI is a procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. The addition of MRI to CT for HDR prostate brachytherapy treatment planning may help patients have less urine leakage and less pain after treatment.
The 2 groups in the trial
- Arm A (CT, SOC HDR brachytherapy)Treatment being tested
Patients undergo treatment planning with a CT scan for HDR brachytherapy.
Treatment: Questionnaire Administration
- Arm B (CT, MRI, SOC HDR brachytherapy)Treatment being tested
Patients undergo treatment planning with a CT scan and MRI scan for HDR brachytherapy.
Treatment: Magnetic Resonance Imaging and Questionnaire Administration
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized Pragmatic Study of CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate Cancer
- Plain-language title
- Comparing CT and MRI scans to plan internal radiation for prostate cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 2 November 2026